7 articles, transcripts, and reports
GW Pharmaceuticals PLC (NASDAQ: GWPH) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Stephen Schultz — Vice President of Investor Relations Justin Gover — Chief Executive Officer…
GW Pharmaceuticals plc (NASDAQ: GWPH) has seen its stock gain over 17% in the past one month. The company delivered topline growth of over 200%…
GW Pharmaceuticals PLC (GWPH) Q1 2020 earnings call dated May. 11, 2020 Corporate Participants: Stephen Schultz — Vice President, Investor Relations Justin Gover — Chief Executive Officer Darren Cline — U.S.…
For GW Pharmaceuticals (NASDAQ: GWPH), the main growth strategy for the current fiscal year is to expand its product pipeline beyond Epidiolex, the highly successful…
GW Pharmaceuticals (NASDAQ: GWPH) reported a narrower net loss for the fourth quarter of 2019 as net sales rose sharply, with strong contributions from the…
GW Pharmaceuticals plc (NASDAQ: GWPH) is slated to report fourth quarter 2019 earnings results on Tuesday, February 25, after the market closes. Analysts have projected…
GW Pharmaceuticals (NASDAQ: GWPH) beat revenue estimates and reported a narrower-than-expected loss for the third quarter of 2019. Despite the beat, the stock tumbled 12% in aftermarket…
